FDA will remain without a confirmed commissioner through 2026

The Senate’s confirmation schedule is already strained by competing nominees for CDC and surgeon general roles, making it unlikely to prioritize a new FDA commissioner before the end of the year. Internal FDA vacancies and political infighting further delay the process.

Implied probability (Yes)

72%